Neovasc Inc.
(Toronto Stock Exchange : NVCN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading NVCN News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.11%89.190.6%$430.57m
ABTAbbott Laboratories
-0.39%49.080.8%$380.47m
ISRGIntuitive Surgical, Inc.
-0.55%948.947.5%$324.23m
ALGNAlign Technology, Inc.
2.55%153.506.2%$292.66m
BDXBecton, Dickinson and Company
0.05%195.161.3%$285.09m
BCRC. R. Bard, Inc.
0.09%316.251.6%$252.30m
TMOThermo Fisher Scientific Inc.
-0.62%174.381.0%$212.41m
BAXBaxter International Inc.
1.14%61.371.7%$206.18m
BSXBoston Scientific Corporation
0.86%28.101.1%$187.50m
SYKStryker Corporation
-0.06%141.131.3%$167.20m
EWEdwards Lifesciences Corporation
1.36%120.141.2%$134.41m
ZBHZimmer Biomet Holdings, Inc.
-0.22%129.101.7%$133.11m
HOLXHologic, Inc.
-0.77%46.131.6%$119.46m
IDXXIDEXX Laboratories, Inc.
0.50%167.353.6%$117.39m
COOCooper Companies, Inc.
0.46%246.192.2%$116.40m

Company Profile

Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.,079DGS-E